Anika Therapeutics, Inc. ANIK
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -109.40% | 165.45% | -1,831.51% | 112.54% | 41.34% |
| Total Depreciation and Amortization | -4.39% | 6.97% | 6.75% | -6.06% | 10.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 49.38% | -53.82% | 92.16% | 22.80% | -46.65% |
| Change in Net Operating Assets | 118.91% | -0.01% | -712.29% | -125.65% | 215.05% |
| Cash from Operations | 1,324.71% | 85.89% | -204.51% | -32.50% | 3,734.92% |
| Capital Expenditure | -14.63% | -1.26% | -120.83% | 65.66% | -28.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -100.00% |
| Other Investing Activities | -156.21% | -11.98% | -77.30% | 445.81% | 104.34% |
| Cash from Investing | -37.19% | -3.31% | -725.76% | 111.43% | -221.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | 97.04% | 91.20% | -87.51% | -42,346.15% | 84.15% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 96.15% | 93.23% | -96.00% | -40,507.69% | -107.26% |
| Foreign Exchange rate Adjustments | -185.96% | 296.55% | 55.38% | 78.48% | -187.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 350.96% | 84.16% | -3,133.99% | -110.55% | 2,464.22% |